tiprankstipranks
NAVCO Pharmaceuticals Inc (TSE:NAV)
:NAV
Canadian Market

NAVCO Pharmaceuticals Inc (NAV) Financial Statements

Compare
4 Followers

NAVCO Pharmaceuticals Inc Financial Overview

NAVCO Pharmaceuticals Inc's market cap is currently C$406.45K. The company's EPS TTM is C$-0.032; its P/E ratio is 0.63; NAVCO Pharmaceuticals Inc is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Jun 22Jun 21Jun 20
Income Statement
Total Revenue
Gross Profit--$ 31.59K--
Operating Income$ -2.11M$ -3.34M$ -211.17K$ -79.54K$ -50.70K
EBITDA$ -2.09M$ -3.33M$ -142.32K$ -74.08K$ -49.56K
Net Income$ -2.15M$ -3.34M$ -216.39K$ -74.08K$ -49.56K
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 931.84K$ 1.31M$ 224.34K$ 116.03K$ 181.28K
Total Debt$ 112.64K$ 115.66K$ 0.00$ 0.00$ 0.00
Net Debt$ -122.03K$ -606.35K$ -3.60K$ -12.07K$ -181.28K
Total Liabilities$ 844.38K$ 685.38K$ 217.40K$ 18.88K$ 20.04K
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -1.78M-$ -56.59K$ -80.71K$ -48.17K
Operating Cash Flow$ -1.78M$ -1.32M$ -56.59K$ -80.71K$ -48.17K
Investing Cash Flow
Financing Cash Flow
Currency in USD

NAVCO Pharmaceuticals Inc Earnings and Revenue History

NAVCO Pharmaceuticals Inc Debt to Assets

NAVCO Pharmaceuticals Inc Cash Flow

NAVCO Pharmaceuticals Inc Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis